Hong Kong, Hong Kong · Founded 2025 · Privately Held (backing)
Developer of RNA-based biopharmaceutical technologies intended to accelerate therapeutic innovation in precision medicine. ALLYRNA is based in Hong Kong, Hong Kong and was founded in 2025. It has raised $10 million.
Last price · $/share
—
Implied valuation
—
Total raised
$10.0M
Last round
—
Cap table — not yet on record
ALLYRNA's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ALLYRNA with a free account
·Watch ALLYRNA: the Monday email on marks, rounds and moves
